Abiopharma

🔍 Rothka John (Executive)

Company: Core Natural Resources, Inc. (CNR)

Report Date: 2026-03-17

Detailed Transactions and Holdings:

• Sold 1,000 shares of Common stock, par value $0.01 per share at $97.66 per share (Direct)
  Date: 2026-03-17 | Code: S | equity_swap_involved: false | shares_owned_after: 5,190.00 | transaction_form_type: 4 | Footnotes: F1, F2

Footnotes:

• F1: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $97.65 to $97.75, inclusive. The reporting person undertakes to provide to Core Natural Resources, Inc., any security holder of Core Natural Resources, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) to this Form 4.
• F2: Of the 5,190 shares reported, 1,314 are unvested restricted stock units.